SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on December 6, 2022, for use of the ...
Mutations of virus and illnesses caused by new variants are still to be expected even in a SARS-CoV-2 situation that has now become endemic. Although the population has developed specific immune ...
In a recent study posted to the bioRxiv* preprint server, researchers described four novel monoclonal antibodies with potent and broad neutralization activity against severe acute respiratory syndrome ...
Therefore, we collected serum samples from participants who had received three doses of either of the original monovalent mRNA vaccines followed by one dose of a bivalent vaccine targeting BA.4–BA.5 ...
A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform. Subscribe to our newsletter for the latest sci-tech news updates ...
This is very exciting! The good activity and highly conserved epitope of this antibody suggested its potential for clinical translation". The team found the mAb-39 greatly improved the neutralizing ...
Imagine the last time you went to the doctor feeling miserable with a cold. If you have ever heard “you have a virus” from your physician, you know exactly what that means. There are no antibiotics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results